Abstract B121: Low dose, metronomic cyclophosphamide therapy sensitizes tumors to CpG-1826 immunotherapy in a preclinical glioma model

2016 ◽  
Author(s):  
Marie Jordan ◽  
David J. Waxman
Keyword(s):  
Low Dose ◽  
Cyclophosphamide Therapy ◽  
Glioma Model ◽  
Metronomic Cyclophosphamide

scholarly journals Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice

2007 ◽  
Vol 6 (8) ◽  
pp. 2280-2289 ◽  
Author(s):  
Urban Emmenegger ◽  
Yuval Shaked ◽  
Shan Man ◽  
Guido Bocci ◽  
Ivan Spasojevic ◽  
...  
Keyword(s):  
Pharmacokinetic Study ◽  
Low Dose ◽  
Cyclophosphamide Therapy ◽  
Metronomic Cyclophosphamide

Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model

2010 ◽  
Vol 288 (2) ◽  
pp. 251-260 ◽  
Author(s):  
Chung Kwon Kim ◽  
Young Ae Joe ◽  
Suk-Keun Lee ◽  
Eun-Kyoung Kim ◽  
Eunju O ◽  
...  
Keyword(s):  
Low Dose ◽  
Kringle Domain ◽  
Dose Combination ◽  
Glioma Model ◽  
Anti Tumor Activity

scholarly journals Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis

1980 ◽  
Vol 23 (5) ◽  
pp. 521-527 ◽  
Author(s):  
H. James Williams ◽  
James C. Reading ◽  
John R. Ward ◽  
William M. O'Brien
Keyword(s):  
Rheumatoid Arthritis ◽  
Low Dose ◽  
Cyclophosphamide Therapy

Low dose metronomic cyclophosphamide, methotrexate (LDCM) and aspirin for patients with residual disease after neoadjuvant chemotherapy for stage II-III breast cancer.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e12040-e12040 ◽  
Author(s):  
Jose Ignacio Ruades Ninfea ◽  
Susan Burdette-Radoux ◽  
Melissa of Sands ◽  
Jamie E Levis ◽  
Mercedes Rincon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Low Dose ◽  
Residual Disease ◽  
Stage Ii ◽  
Metronomic Cyclophosphamide

Hepatotoxıcıty After Low-dose Cyclophosphamide Therapy

2006 ◽  
Vol 99 (12) ◽  
pp. 1399-1400 ◽  
Author(s):  
Hakan Akay ◽  
Tuba Akay ◽  
Sema Secilmis ◽  
Zeliha Kocak ◽  
Ömer Donderici
Keyword(s):  
Low Dose ◽  
Cyclophosphamide Therapy

Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial

2016 ◽  
Vol 33 (8) ◽  
Author(s):  
Fabien Calcagno ◽  
Guillaume Mouillet ◽  
Olivier Adotevi ◽  
Tristan Maurina ◽  
Thierry Nguyen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Recurrent Prostate Cancer ◽  
Cyclophosphamide Therapy ◽  
Metronomic Cyclophosphamide
Sign in / Sign up

Export Citation Format

Share Document